- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 261/00 - Derivatives of cyanic acid
Patent holdings for IPC class C07C 261/00
Total number of patents in this class: 60
10-year publication summary
|
5
|
4
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Asahi Kasei Chemicals Corporation | 678 |
5 |
| SK Biopharmaceuticals Co., Ltd. | 261 |
4 |
| Covestro Deutschland AG | 2754 |
3 |
| Arbor Pharmaceuticals, LLC | 69 |
2 |
| ISP Investments Inc. | 459 |
2 |
| Signature Therapeutics, Inc. | 37 |
2 |
| Waters Technologies Corporation | 1697 |
2 |
| XenoPort, Inc. | 89 |
2 |
| Merck Sharp & Dohme LLC | 3742 |
2 |
| Hoffmann-La Roche Inc. | 3428 |
1 |
| BASF SE | 20915 |
1 |
| Xerox Corporation | 7000 |
1 |
| Honeywell International Inc. | 13567 |
1 |
| Mitsui Chemicals, Inc. | 3220 |
1 |
| National Institute of Advanced Industrial Science and Technology | 3791 |
1 |
| Amyris, Inc. | 373 |
1 |
| Bio-Pharm Solutions Co., Ltd. | 60 |
1 |
| Cellix Bio Private Limited | 52 |
1 |
| CTC bio, Inc. | 45 |
1 |
| Daiichi Sankyo Company, Limited | 1874 |
1 |
| Other owners | 25 |